ResMed | RMD - Operating Profit

Stock Price
262.65
Daily Change
11.24 4.47%
Monthly
7.05%
Yearly
8.27%
Q1 Forecast
250.35

ResMed reported $497.6M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Ansell USD 58.65M 19.15M Jun/2024
AtriCure USD 208K 4.03M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Cochlear AUD 125.55M 149.05M Jun/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
CSL USD 666M 1.31B Jun/2025
Dexcom USD 242.5M 29.9M Sep/2025
Edwards Lifesciences USD 425.1M 5.8M Sep/2025
Fisher Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 58.49M 12.35M Sep/2025
Hologic USD 237M 16M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.7B 100M Sep/2025
Philips EUR 329M 159M Sep/2025
Ramsay Health Care AUD 537.2M 337.2M Jun/2025
ResMed USD 497.6M 35.25M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Steris USD 270.9M 45.6M Sep/2025
Teleflex USD -408.9M 586.38M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025